Literature DB >> 7698252

Adhesion activity in fibronectin's alternatively spliced domain EDa (EIIIA): complementarity to plasma fibronectin functions.

P Xia1, L A Culp.   

Abstract

The EDa (EIIIA) domain is one of two alternatively spliced type III homology repeats in fibronectins which differentiate cellular (cFN) from plasma isoforms (pFN). A bacteria-expressed recombinant polypeptide encoding the EDa type III repeat promotes adhesion of some cell types and its activity is synergistic with neighboring repeats III11 and III12. We show in this study that co-coating substrata with the EDa-only polypeptide and a suboptimal concentration of pFN leads to increased attachment and extensive spreading of v-src-transformed 3T3 cells relative to that found on substrata of suboptimal pFN or EDa polypeptide alone. This complementarity of activities requires as little as 1 microgram/ml EDa polypeptide in the adsorbing mixture and displays sequence specificity for only EDa (recombinant polypeptides of neighboring repeats III11 or III12 were without effect). Furthermore, stress fibers and focal contacts are inducible on the EDa:pFN mixture, suggesting that the EDa sequence and its receptor participate in signal transduction. The codistribution of phosphotyrosine proteins, including pp125FAK, along with vinculin and talin into focal contacts supports this hypothesis. Therefore, an alternatively spliced domain EDa which is expressed in various proportions in cells and tissues may have special functions related to adhesion processes by complementing the functions of pFN circulating in blood.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7698252     DOI: 10.1006/excr.1995.1117

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  15 in total

1.  NMR structure of human fibronectin EDA.

Authors:  T Niimi; M Osawa; N Yamaji; K Yasunaga; H Sakashita; T Mase; A Tanaka; S Fujita
Journal:  J Biomol NMR       Date:  2001-11       Impact factor: 2.835

2.  EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha4beta7 integrin receptor and MAPK/Erk 1/2-dependent signaling.

Authors:  Martin Kohan; Andres F Muro; Eric S White; Neville Berkman
Journal:  FASEB J       Date:  2010-07-19       Impact factor: 5.191

3.  Fibronectin-alpha4beta1 integrin interactions regulate metalloproteinase-9 expression in steatotic liver ischemia and reperfusion injury.

Authors:  Carolina Moore; Xiu-Da Shen; Feng Gao; Ronald W Busuttil; Ana J Coito
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

4.  Adhesion to fibronectin's EDb domain induces tyrosine phosphorylation of focal adhesion proteins in Balb/c 3T3 cells.

Authors:  W Chen; L A Culp
Journal:  Clin Exp Metastasis       Date:  1998-01       Impact factor: 5.150

5.  Expression of fibronectin splicing variants in organ transplantation: a differential pattern between rat cardiac allografts and isografts.

Authors:  A J Coito; L F Brown; J H Peters; J W Kupiec-Weglinski; L van de Water
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

6.  Cell adhesion and migration are regulated at distinct stages of thymic T cell development: the roles of fibronectin, VLA4, and VLA5.

Authors:  L Crisa; V Cirulli; M H Ellisman; J K Ishii; M J Elices; D R Salomon
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

Review 7.  New insights into form and function of fibronectin splice variants.

Authors:  E S White; F E Baralle; A F Muro
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

8.  Transforming growth factor-beta1 regulates fibronectin isoform expression and splicing factor SRp40 expression during ATDC5 chondrogenic maturation.

Authors:  Fei Han; James R Gilbert; Gerald Harrison; Christopher S Adams; Theresa Freeman; Zhuliang Tao; Raihana Zaka; Hongyan Liang; Charlene Williams; Rocky S Tuan; Pamela A Norton; Noreen J Hickok
Journal:  Exp Cell Res       Date:  2007-02-28       Impact factor: 3.905

9.  The monoclonal antibody SM5-1 recognizes a fibronectin variant which is widely expressed in melanoma.

Authors:  Uwe Trefzer; Yingwen Chen; Gunda Herberth; Maja Ann Hofmann; Felix Kiecker; Yajun Guo; Wolfram Sterry
Journal:  BMC Cancer       Date:  2006-01-11       Impact factor: 4.430

10.  Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan.

Authors:  Andres F Muro; Anil K Chauhan; Srecko Gajovic; Alessandra Iaconcig; Fabiola Porro; Giorgio Stanta; Francisco E Baralle
Journal:  J Cell Biol       Date:  2003-07-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.